Pfizer
Patents, Design & Utilities

Last updated:

List of all Pfizer patents 451 in total

Status Patent
Application
Utility: 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES External link
Filling date: 13 Sep 2025 Issue date: 2 Jul 2020
Grant
Utility: Heteroaromatic compounds and their use as dopamine D1 ligands External link
Filling date: 13 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Dual-ended lip balm container External link
Filling date: 13 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Combination of a PD-1 antagonist and an ALK inhibitor for treating cancer External link
Filling date: 13 Sep 2025 Issue date: 30 Jun 2020
Application
Utility: Novel Polymorphic Forms of a TGFBeta Inhibitor External link
Filling date: 13 Sep 2025 Issue date: 25 Jun 2020
Grant
Utility: Site specific HER2 antibody drug conjugates External link
Filling date: 13 Sep 2025 Issue date: 23 Jun 2020
Application
Utility: TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: CIRCULATING TUMOR CELL ASSAY External link
Filling date: 13 Sep 2025 Issue date: 18 Jun 2020
Grant
Utility: GLP-1 receptor agonists and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 16 Jun 2020
Application
Utility: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS External link
Filling date: 13 Sep 2025 Issue date: 11 Jun 2020
Grant
Utility: GLP-1 receptor agonists and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Cycloalkyl-linked diheterocycle derivatives External link
Filling date: 13 Sep 2025 Issue date: 9 Jun 2020
Application
Utility: Chemical Compounds External link
Filling date: 13 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: Azalactam Compounds as HPK1 Inhibitors External link
Filling date: 13 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: PYRAZOLO[1,5-A]PYRAZIN-4-YL AND RELATED DERIVATIVES External link
Filling date: 13 Sep 2025 Issue date: 4 Jun 2020
Grant
Utility: Imidazopyridazine compounds External link
Filling date: 13 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: GLP-1 receptor agonists and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Immunogenic glycoprotein conjugates External link
Filling date: 13 Sep 2025 Issue date: 2 Jun 2020
Application
Utility: COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN External link
Filling date: 13 Sep 2025 Issue date: 28 May 2020
Application
Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF External link
Filling date: 13 Sep 2025 Issue date: 28 May 2020
Grant
Utility: Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents External link
Filling date: 13 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Formulations of a PI3K/mTOR-inhibitor for intravenous administration External link
Filling date: 13 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Methods for purifying FXa variant proteins External link
Filling date: 13 Sep 2025 Issue date: 26 May 2020
Application
Utility: 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS External link
Filling date: 13 Sep 2025 Issue date: 21 May 2020
Application
Utility: ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 21 May 2020
Grant
Utility: Capped and uncapped antibody cysteines, and their use in antibody-drug conjugation External link
Filling date: 13 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Immunogenic compositions for use in pneumococcal vaccines External link
Filling date: 13 Sep 2025 Issue date: 19 May 2020
Application
Utility: SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS External link
Filling date: 13 Sep 2025 Issue date: 14 May 2020
Grant
Utility: Humanized antibodies External link
Filling date: 13 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Tofacitinib oral sustained release dosage forms External link
Filling date: 13 Sep 2025 Issue date: 5 May 2020
Grant
Utility: 4-1BB binding molecules External link
Filling date: 13 Sep 2025 Issue date: 5 May 2020
Application
Utility: NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF External link
Filling date: 13 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF External link
Filling date: 13 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: BISPECIFIC ANTIBODIES External link
Filling date: 13 Sep 2025 Issue date: 23 Apr 2020
Grant
Utility: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors External link
Filling date: 13 Sep 2025 Issue date: 21 Apr 2020
Grant
Utility: Synergistic auristatin combinations External link
Filling date: 13 Sep 2025 Issue date: 14 Apr 2020
Application
Utility: Boron Containing PDE4 Inhibitors External link
Filling date: 13 Sep 2025 Issue date: 9 Apr 2020
Grant
Utility: Human cytomegalovirus gB polypeptide External link
Filling date: 13 Sep 2025 Issue date: 7 Apr 2020
Application
Utility: Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) External link
Filling date: 13 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: ANTI-CXCR4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES External link
Filling date: 13 Sep 2025 Issue date: 2 Apr 2020
Grant
Utility: 5,7-dihydro-pyrrolo-pyridine derivatives External link
Filling date: 13 Sep 2025 Issue date: 31 Mar 2020
Application
Utility: Pemetrexed Polymeric Nanoparticles And Methods Of Making And Using Same External link
Filling date: 13 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDES USEFUL AS CCR6 INHIBITORS External link
Filling date: 13 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: ANTIBODIES TO COAGULATION FACTOR XIa AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 26 Mar 2020
Grant
Utility: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Tetrahydroquinazoline derivatives useful as anticancer agents External link
Filling date: 13 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Compositions and methods for counteracting Factor Xa inhibition External link
Filling date: 13 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands External link
Filling date: 13 Sep 2025 Issue date: 17 Mar 2020
Application
Utility: ANTI-AVB8 ANTIBODIES AND COMPOSITIONS AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 12 Mar 2020
Grant
Utility: Therapeutic nanoparticles comprising a protonatable nitrogen therapeutic agent and methods of making and using same External link
Filling date: 13 Sep 2025 Issue date: 10 Mar 2020

Showing 300 to 350 of 451 patents.